Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1995 1
1996 1
1997 1
1999 1
2000 1
2001 1
2002 2
2003 2
2004 1
2005 1
2006 2
2007 2
2008 1
2009 1
2010 8
2011 3
2012 2
2013 1
2014 6
2015 7
2016 4
2017 3
2018 2
2019 4
2020 6
2021 10
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacological basis for cladribine resistance.
Lotfi K, Juliusson G, Albertioni F. Lotfi K, et al. Leuk Lymphoma. 2003 Oct;44(10):1705-12. doi: 10.1080/1042819031000099698. Leuk Lymphoma. 2003. PMID: 14692522 Review.
Mechanisms of anti-cancer action and pharmacology of clofarabine.
Zhenchuk A, Lotfi K, Juliusson G, Albertioni F. Zhenchuk A, et al. Among authors: lotfi k. Biochem Pharmacol. 2009 Dec 1;78(11):1351-9. doi: 10.1016/j.bcp.2009.06.094. Epub 2009 Jul 1. Biochem Pharmacol. 2009. PMID: 19576186 Free article. Review.
Monitoring oral cyclosporine therapy.
Lotfi K, Peterson C, Juliusson G. Lotfi K, et al. Bone Marrow Transplant. 2005 Aug;36(4):367. doi: 10.1038/sj.bmt.1705055. Bone Marrow Transplant. 2005. PMID: 15968286 No abstract available.
Cardiac arrest in schools.
Lotfi K, White L, Rea T, Cobb L, Copass M, Yin L, Becker L, Eisenberg M. Lotfi K, et al. Circulation. 2007 Sep 18;116(12):1374-9. doi: 10.1161/CIRCULATIONAHA.107.698282. Epub 2007 Aug 27. Circulation. 2007. PMID: 17724258
A novel stochastic wastewater quality modeling based on fuzzy techniques.
Lotfi K, Bonakdari H, Ebtehaj I, Delatolla R, Zinatizadeh AA, Gharabaghi B. Lotfi K, et al. J Environ Health Sci Eng. 2020 Sep 14;18(2):1099-1120. doi: 10.1007/s40201-020-00530-8. eCollection 2020 Dec. J Environ Health Sci Eng. 2020. PMID: 33312627 Free PMC article.
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI.
Richter J, Lübking A, Söderlund S, Lotfi K, Markevärn B, Själander A, Stenke L, Deneberg S, Ahlstrand E, Myhr-Eriksson K, Panayiotidis P, Gedde-Dahl T, Žáčková D, Mayer J, Olsson-Strömberg U, Mahon FX, Saussele S, Hjorth-Hansen H, Koskenvesa P. Richter J, et al. Among authors: lotfi k. Leukemia. 2021 Aug;35(8):2416-2418. doi: 10.1038/s41375-021-01173-w. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589755 Free PMC article. No abstract available.
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.
Malyukova A, Ujvari D, Yektaei-Karin E, Zovko A, Madapura HS, Keszei M, Nagy N, Lotfi K, Björn N, Wallvik J, Tamai M, Nguyen TTT, Akahane K, Inukai T, Stenke L, Salamon D. Malyukova A, et al. Among authors: lotfi k. Cell Death Dis. 2021 Sep 25;12(10):875. doi: 10.1038/s41419-021-04154-0. Cell Death Dis. 2021. PMID: 34564697 Free PMC article.
76 results